French surgeon performs first spine surgery using Expanding Orthopedics’ FLXfit

The first surgery using the FLXfit from Expanding Orthopedics was performed in France.

Advertisement

The company received FDA clearance for the FLXfit in July. It is the world’s first three-dimensional expandable interbody cage cleared for commercialization in the United States. The cage is designed for minimally invasive spine surgery and maximum footprint support.

 

Prof. Jean-Charles Le Huec performed the first procedure. The company also plans the first distribution agreement in the United States — and the first U.S. procedure — soon. Dr. Le Huec presented a paper at the International Society for the Advancement of Spine Surgery annual meeting on the FLXfit.

 

“The current cages available on the market have limited possibilities for lordosis correction and are sometimes difficult to maneuver,” said Dr. Le Huec. “In addition, the contact between the implant and endplate is not always optimal, leading to improper stability after surgery.”

 

The FLXfit allows for a wide anterior footprint coverage in minimally invasive, unilateral TLIF approaches. It has articulated self-guidance features for optimal placement after expansion.

 

More articles on spine surgery:
What is a spine surgeon’s responsibility for patient-centric care? 5 key thoughts
Another victory for MIS SI joint fusion — Priority Health to cover
Cervical spine surgery outcomes: 5 findings on racial differences

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.